The Norwegian Institute of Public Health would like to procure vaccines against Hepatitis B for the national vaccination programme.

In 2014 the Norwegian Institute of Public Health will procure 45 000 child doses (0-15 years) and 8 000 adult doses (16 or older) of the vaccine against Hepatitis B for use in the vaccination programme. The Norwegian Institute of Public Health expects that the consumption of the vaccination against Hepatitis B will stay relatively stable. The Norwegian Institute of Public Health requires, therefore that tenderers have the capacity to deliver at least 49 500 doses for children and 8 800 doses for adults per annum.

The Ministry of Health and Care Services has given the Norwegian Institute of Public Health the task of preparing a draft for a strategy for viral hepatitises. One of the points that is to be reviewed is the possibility to include the vaccine against Hepatitis B in the child vaccination programme. If it is included in the child vaccination programme, there will be consequences for the extent of this procurement. As a result of this, the Norwegian Institute of Public Health is announcing a 1-one year contract, with an option for an extension of 1+1+1 years.

In order to minimise any disadvantages connected to the length, the Norwegian Institute of Public Health is offering to procure a minimum volume of 45 000 child doses (0 - 15 years) and 8 000 adult doses (16 or older) respectively.

See the tender documentation and annexes for a complete description.